Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Coronary Artery Disease V: Interprofessional Care
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 25, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
1Lourdes Community Nursing Home in Westgate-on-Sea, Kent.
Low-density lipoprotein (LDL) plays a key role in the development of atherosclerosis. Understanding this mechanism is crucial for managing cardiovascular disease risk and preventing atheroma formation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: